
[Expand/Collapse all sections]Expand all

This document outlines details of PBS-subsidised daratumumab for
patients with systemic light chain amyloidosis.

AL and listing dates

Systemic light chain amyloidosis is a rare disease that occurs when a
protein called amyloid builds up in organs.

Listing date:

-   daratumumab - 1 January 2023

See Written Authority Required Drugs for more information.

Enquiries

Transfer enquiries about prescription arrangements to the PBS authority
approvals line.

The Resources page contains links to application forms, contact details,
the PBS schedule and the Services Australia website.

Related links

Tier 0 technical support - self-sufficiency

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA
System)

Process telephone Authority approval application

Processing and National Demand Allocation (PaNDA)

Processing written authority approval requests

Written Authority Required Drugs

                                   

-   Services Australia ABN 90 794 605 008 
